Abstract Details
|
Ruth-Ann Marrie, MD, PhD
(University of Manitoba)
PRESENTER |
The institution of Dr. Marrie has received research support from CIHR. The institution of Dr. Marrie has received research support from MS Canada. The institution of Dr. Marrie has received research support from National MS Society. The institution of Dr. Marrie has received research support from Crohn's and Colitis Canada. The institution of Dr. Marrie has received research support from US Department of Defense. The institution of Dr. Marrie has received research support from The Arthritis Society. The institution of Dr. Marrie has received research support from CMSC. |
| Scott Patten, PhD (Univ of Calgary, Community Health Sciences) | Dr. Patten has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Canadian Psychiatric Association. Dr. Patten has received publishing royalties from a publication relating to health care. |
| Jamie Greenfield | No disclosure on file |
| Helen Tremlett, PhD, BPharm (University of British Columbia) | Dr. Tremlett has nothing to disclose. |
| No disclosure on file | |
| Sharon A. Warren, PhD (University of Alberta) | No disclosure on file |
| No disclosure on file | |
| Nathalie Jette, MD, MSc, FRCPC, FAAN (University of Calgary) | Dr. Jette has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ILAE Epilepsia. The institution of Dr. Jette has received research support from NIH. The institution of Dr. Jette has received research support from AES. |
| John D. Fisk, PhD (Nova Scotia Health) | The institution of Dr. Fisk has received research support from Canadian Institutes of Health Research. The institution of Dr. Fisk has received research support from Multiple Sclerosis Society of Canada. Dr. Fisk has received publishing royalties from a publication relating to health care. |